News
Thu 11 Sep 2025
Kantify at the CONDOR Symposium on Sarcoma
Kantify will participate at the annual event of the CONDOR Symposium which will focus on Microenvironment And Immunotherapy Of Sarcomas
Wed 11 Jun 2025
Kantify Contributes to the EU Biotech Act Consultation
Kantify has submitted its contribution to the European Commission’s consultation on the upcoming “EU Biotech Act”—a critical initiative to advance biotechnology
Wed 04 Jun 2025
AI & drug discovery: presentation at Laminopathy Conference
Kantify presents how AI helps with rare neuromuscular disorders drug discovery at the 5th International Laminopathy Conference
Tue 06 May 2025
AI and Repurposing: Kantify's COO at iDR25
Nicolas Maignan to deliver a presentation about AI for repurposing at the International Drug Repurposing Conference 2025
Wed 29 Jan 2025
Kantify Pipeline Announcement
Kantify discloses pipeline of drugs and targets discovered by Sapian AI
Tue 19 Nov 2024
AI for plants based drug discovery: Kantify lecture at IBMCP
How can AI accelerate target discovery and small molecule discovery in plants? First lecture at IBMCP
Tue 19 Nov 2024
Kantify announced as speaker at BioFIT 2024
Kantify will be speaking at the BioFIT event
Thu 22 Aug 2024
DREAMS: when AI finds drugs for rare diseases
Discover on the DREAMS project website how Kantify contributes to the discovery of therapeutic targets and treatments for 5 rare neuromuscular disorders
Tue 30 Jul 2024
AI unveils secret targets of drugs, starting with Viagra
In a new White Paper, Kantify presents its AI powered Drug Atlas and unveils the predicted targets for Sildenafil (Viagra)
Wed 24 Jul 2024
A new name for the Kantify AI platform for drug discovery
Kantify shares the new name for its AI platform for small molecule and target discovery
Thu 11 Jul 2024
Kantify to speak at Science for Health
Join us at Science for Health, the flagship event Biology meets technology: AI, Data & Digitalization
Tue 30 Apr 2024
New poster on AI for drug discovery for muscular dystrophies
At Myology 2024, Emilie PELLIER & Quentin MIAGOUX from i-Stem presented our collaboration on AI powered target and drug discovery for LGMDR2